A quiet change in North Dakota law gives pharmacists new authority to swap medications—and it affects your inventory, workflow, and liability.
Most North Dakota retail pharmacy owners don't realize that as of the filing of SB2402 with the Secretary of State, their pharmacists have gained a significant new power: they can now dispense a therapeutically equivalent drug in place of what a doctor prescribed—without asking the prescriber first.
This isn't a small procedural tweak. It's a real change to how your pharmacy operates, and it affects decisions you make every day about stock, staffing, and risk.
Under Section 4 of SB2402 (Page 8), pharmacists may substitute a therapeutically equivalent drug for the one prescribed. "Therapeutically equivalent" means the substitute has the same active ingredient and strength as the original, and produces the same clinical effect—but it may be a different brand, a generic version, or simply what you have in stock.
The catch: three things must happen.
First, the patient must consent. Your pharmacist needs to get agreement before making the swap. Second, the patient must receive counseling about the change. Third, you must notify the prescriber within 24 hours that a substitution was made.
That's it. You don't need pre-approval. You don't need to wait for a call back. You notify after.
For small pharmacy operations, this opens real flexibility. If a prescribed brand-name drug is out of stock, your pharmacist can dispense the generic equivalent without delay. If a therapeutically equivalent medication costs less and the patient agrees, you can fill it immediately. Your workflow speeds up. Patients get their medications faster. You reduce the number of calls back to prescribers' offices.
But there are operational decisions to make. You'll want clear protocols for how your team documents consent and counseling. You'll need a system to ensure that 24-hour prescriber notification actually happens—and gets recorded. Your liability insurance should account for this new authority. And your staff training needs to cover when substitution is appropriate and how to handle patient conversations.
SB2402 became effective upon filing with the North Dakota Secretary of State (Section 7, Page 9). There's no delayed implementation window. The law is in effect now.
If you haven't already, review the full text of Section 4 on Page 8 of SB2402. Talk with your pharmacist-in-charge about your current dispensing protocols and whether they align with this new authority. Document your consent and notification procedures in writing. Consider whether your inventory strategy should shift—you may be able to stock more generics and fewer brand-name equivalents.
This law gives your pharmacy more operational freedom. Using it well means being intentional about how you implement it.
Source: North Dakota SB2402, "Approved laboratory tests; and to provide an effective date," Section 4 (Page 8) and Section 7 (Page 9).